Clinical Trial Update: Safety Study of Itacitinib (INCB039110) in Combination With Gemcitabine and Nab-Paclitaxel in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A safety study of itacitinib in combination with gemcitabine and nab-paclitaxel in advanced solid tumors completed Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer
• Solid Tumors

Drugs mentioned

• Gemcitabine (Gemcitabine)
• Itacitinib (itacitinib)
• Nab-paclitaxel (paclitaxel protein-bound)

Snippet

Sponsor: Incyte Corporation | Conditions: Solid Tumors, Pancreatic Cancer | Phase 1, Phase 2 | Status: COMPLETED